SARCOIDOSIS, PULMONARY
Clinical trials for SARCOIDOSIS, PULMONARY explained in plain language.
Never miss a new study
Get alerted when new SARCOIDOSIS, PULMONARY trials appear
Sign up with your email to follow new studies for SARCOIDOSIS, PULMONARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a malaria drug help sarcoidosis patients ditch steroids?
Disease control Recruiting nowThis study tests if hydroxychloroquine, a drug used for malaria and autoimmune diseases, can help people with sarcoidosis reduce or stop taking steroids. Sarcoidosis causes inflammation, often in the lungs, but this trial focuses on cases affecting the skin, eyes, or bones. 140 a…
Matched conditions: SARCOIDOSIS, PULMONARY
Phase: PHASE4 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 26, 2026 17:09 UTC
-
Weight loss drug ozempic tested in lung disease patients
Symptom relief Recruiting nowThis pilot study tests whether semaglutide (Ozempic), a drug used for diabetes and obesity, is safe and tolerable for weight loss in people with advanced lung disease. Eight participants with conditions like COPD or pulmonary fibrosis will take weekly injections for 12 weeks. Res…
Matched conditions: SARCOIDOSIS, PULMONARY
Phase: PHASE1, PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New study aims to predict lung outcomes in sarcoidosis patients
Knowledge-focused Recruiting nowThis study is developing prediction models to forecast lung function changes in people with sarcoidosis, a condition that causes inflammation in the lungs. Researchers will collect clinical data and blood markers from 200 adults during routine clinic visits. The goal is to create…
Matched conditions: SARCOIDOSIS, PULMONARY
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC